Product
HB-302/HB-301 Alternating 2-Vector Therapy
1 clinical trial
1 indication
Indication
Prostate CancerClinical trial
A Phase 1/2 Study of Replicating Arenavirus-based Vector(s) Encoding Prostate Cancer-Associated Antigens in Participants With Metastatic Castration-Resistant Prostate CancerStatus: Recruiting, Estimated PCD: 2024-09-01